Transcranial Magnetic Stimulation for Chemotherapy-Induced Peripheral Neuropathy in Breast and Gynecologic Cancer Survivors

The goal of this study is to evaluate the change in pain scores among patients with chemotherapy-induced peripheral neuropathy after receiving treatment with repetitive transcranial magnetic stimulation (rTMS).

Trial Details

NCT ID
NCT07120100
Phase
NA
Sponsor
University of Utah
Status
RECRUITING
Cancer Type
Breast Cancer
Interventions
  • rTMS
Locations (sample)
  • Salt Lake City, Utah, United States|40.76078,-111.89105

Key Eligibility Criteria

  • Female subjects aged ≥ 18 years.
  • Histologically confirmed breast or gynecologic cancer.
  • Developed neuropathic pain with the initiation of or within one month after completion of treatment with anti-neoplastic agents from the following …
  • Platinum-based drugs

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Breast Cancer Trials on Trialify →